Mostrando 7 resultados de: 7
Publisher
Basic and Clinical Pharmacology and Toxicology(2)
Journal of Pharmaceutical Health Services Research(2)
PLoS ONE(1)
Pharmacoepidemiology and Drug Safety(1)
Revista Panamericana de Salud Publica/Pan American Journal of Public Health(1)
Área temáticas
Farmacología y terapéutica(4)
Problemas sociales y servicios a grupos(4)
Medicina y salud(3)
Producción(3)
Enfermedades(2)
Origen
scopus(7)
Anticholinergic Exposure in a Cohort of Adults Aged 80 years and Over: Associations of the MARANTE Scale with Mortality and Hospitalization
ArticleAbstract: Anticholinergics are frequently prescribed for older adults and can lead to adverse drug events. ThePalabras claves:Autores:Azermai M., Carlos E. Durán, Christiaens T., Dalleur O., Degryse J., Elseviers M., Klamer T., Vaes B., Vander Stichele R., Wauters M.Fuentes:scopusA Novel Scale Linking Potency and Dosage to Estimate Anticholinergic Exposure in Older Adults: the Muscarinic Acetylcholinergic Receptor ANTagonist Exposure Scale
ArticleAbstract: Quantification of the anticholinergic exposure insufficiently or imprecisely incorporates dosage infPalabras claves:Autores:Azermai M., Carlos E. Durán, Christiaens T., Elseviers M., Klamer T., Vander Stichele R., Wauters M.Fuentes:scopusSharp rise in the expenditures of targeted drugs in Ecuador: five-year (2010–2014) consumption of oncologic drugs in public and private hospitals
ArticleAbstract: Objective: In Ecuador, a new constitutional mandate (2008) allowed the government to implement freePalabras claves:Cáncer, drug utilization, ECUADOR, health expenditures, Latin America, molecular targeted therapy, oncologic drugsAutores:Carlos E. Durán, Christiaens T., Elseviers M., Rottey S., Vander Stichele R.Fuentes:scopusRegulatory reliance to approve new medicinal products in Latin American and Caribbean countries
ArticleAbstract: Objective. To describe the current status of regulatory reliance in Latin America and the CaribbeanPalabras claves:Caribbean Region, Drug approval, Government Agencies, Latin America, Pan american health organization, Pharmaceutical preparations, United States Food and Drug AdministrationAutores:Andia T., Cañás M., Carlos E. Durán, Christiaens T., Elseviers M., Stichele R.V., Urtasun M.A.Fuentes:scopusPolicies influencing access to new targeted oncologic drugs in Ecuadorian hospitals: an interrupted time series analysis
ArticleAbstract: Objective and methods: An interrupted time series analysis was performed to measure the impact of twPalabras claves:antineoplastic drugs, drug and therapeutic committees, drug policies, ECUADOR, interrupted time series analysis, molecular targeted therapyAutores:Carlos E. Durán, Christiaens T., Elseviers M., Patricia Granja, Rottey S., Vander Stichele R.Fuentes:scopusPotential negative impact of reputed regulators decisions on the approval status of new cancer drugs in Latin American countries: A descriptive analysis
ArticleAbstract: Background Many new cancer drugs are being approved by reputed regulatory authorities without evidenPalabras claves:Autores:Cañás M., Carlos E. Durán, Christiaens T., Elseviers M., Stichele R.V., Urtasun M.A.Fuentes:scopusSystematic review of cross-national drug utilization studies in Latin America: Methods and comparability
ReviewAbstract: Purpose: We systematically review the cross-national drug utilization studies performed in Latin AmePalabras claves:Cross-national comparison, drug utilization research, Latin America, Methods, pharmacoepidemiologyAutores:Acosta A., Carlos E. Durán, Christiaens T., Vander Stichele R.Fuentes:scopus